HOYA Vision Care Releases Results of Three-Year MiYOSMART Spectacle Lens Follow-up Study
PR89234
BANGKOK, April 28, 2021 /PRNewswire=KYODO JBN/ --
-- Strong evidence shows continued lens effectiveness in slowing myopia
progression in children in third year
HOYA Vision Care (
), a leader in optical technology innovation, shared the results of a
three-year follow-up clinical study on its award winning MiYOSMART spectacle
lens with patented Defocus Incorporated Multiple Segments (D.I.M.S.) Technology
after releasing the information at the recent European Academy of Optometry and
Optics (EAOO) '21 conference. The new study (
), published in March 2021 in the British Journal of Ophthalmology, was
conducted by the Centre for Myopia Research at The Hong Kong Polytechnic
University and follows-up on the two-year study which previously demonstrated
evidence of the effectiveness of the lens in slowing down the progression of
myopia in children ages 8-13(1).
Logo - https://mma.prnewswire.com/media/1497255/HOYA_Vision_Care_Logo.jpg
The three-year follow-up study, conducted on 120 children in Asia, included 65
from the original group using MiYOSMART lens who took part in the previous
study and 55 children who moved from using a single-vision lens for two years
to the MiYOSMART lens in the third year. At the end of the third year, results
in the original group of children using MiYOSMART lens showed that slowing in
myopia progression over time was sustained and the group that moved from
regular single-vision to MiYOSMART spectacle lens showed a significant and
immediate slow-down in the progression of myopia.
Launched in some markets in mid-2018, the MiYOSMART spectacle lens was
developed in cooperation with The Hong Kong Polytechnic University to address
myopia, or near sightedness which is a growing global health concern with
industry experts predicting nearly 50% of the world's population to be impacted
by 2050. The lens uses patented D.I.M.S. Technology that provides children with
sharp vision, can be placed in any children's eyeglass frame and appears as a
regular lens. Based on the three-year follow-up study, the MiYOSMART lens can
slow and in some cases halt myopia progression by utilizing myopic defocus.
"The results of the three-year study on the MiYOSMART lens are very positive
with the lens continuing to address the growing problem of myopia in children,"
said Griff Altmann, Chief Technology Officer at HOYA Vision Care. "HOYA Vision
Care is proud to be a leader in developing a safe, effective way to manage the
growing problem and we will work diligently to continue to roll out MiYOSMART
globally."
The award winning MiYOSMART lens won the coveted Grand Prize, Grand Award and
Gold Medal at the 46th International Exhibition of Inventions of Geneva in
April 2018. In October 2020, the lens was awarded the Silmo d'Or Award in the
Vision Category at the Silmo Paris Optical show.
(1)Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T,
To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow
myopia progression: a 2-year randomized clinical trial. British Journal of
Ophthalmology. Published Online First: 29 May 2019. doi:
10.1136/bjophthalmol-2018-313739
PRODUCT DISCLAIMER - MiYOSMART has not been approved for myopia management in
all countries, including the U.S., and is not currently available for sale in
all countries, including the U.S.
About HOYA Vision Care
For over 60 years, HOYA Vision Care has been a passionate and global leader in
optical technology innovation. As a manufacturer of high quality, high
performing eyeglass lenses, HOYA continues to drive optical technology
innovation with the aim of finding the best vision care solutions for Eye Care
Professionals. The company supplies lenses in 52 countries with a network of
over 18,000 employees and 45 laboratories around the globe.
Follow HOYA Vision Care on LinkedIn (
)
SOURCE: HOYA Vision Care
CONTACT: HOYA Vision Care PR Contact, Susan Brown, susan@wearenomads.com,
Mobile: +1 831 233 4616
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。